Breaking News

Parexel, Palantir Expand AI Alliance

Aims to accelerate clinical data delivery and power clinical outcomes.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Parexel, a CRO providing the full range of Phase I to IV clinical development services, and Palantir Technologies Inc., a builder of Artificial Intelligence (AI) systems, entered a multi-year strategic partnership to leverage AI to help enhance and accelerate the delivery of safe and effective clinical trials for biopharmaceutical customers.    Parexel will leverage Palantir’s Foundry and Artificial Intelligence Platform (AIP) to further power its clinical data platform, focused on driving cli...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters